Preclinical Drug Discovery Scientist

Вакансия № 10240753 от компании Insilico Medicine, Inc на Электронной Службе Занятости Населения Москвы.

✷ Смотрите другие предложения работы от компании Insilico Medicine, Inc.

☑ Основной блок:

Опыт работы: 1–3 года.

Тип занятости: полная занятость.

График работы: полный день.

Зарплата: по результату собеседования.

Место работы (точный адрес): Россия, Москва, Западный административный округ, Можайский район, Инновационный центр Сколково, район Технопарк.

☑ Актуальность объявления:

Это объявление № 10240753 добавлено в базу данных: Понедельник, 3 февраля 2025 года.

Дата его обновления на этом интернет-ресурсе: Воскресенье, 16 марта 2025 года.

☑ Статистика предложения работы № 10240753:

Прочитано соискателями - 121 раз(а);
Отправлено откликов - 0 раз(а);

☑ Репутация компании "Insilico Medicine, Inc":

Читайте свежие отзывы сотрудников об этом работодателе здесь!

Оставить своё мнение об этой компании можно тут без регистрации и бесплатно.

☑ Подробности о вакантном месте:

About INSILICO MEDICINE:

Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, China, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through end-to-end drug discovery pipeline. It specializes in generative adversarial networks, reinforcement learning, transfer learning, and meta-learning technologies. In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies for its social impact. In 2018, Insilico was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan 2018 North American Artificial Intelligence for Aging Research and Drug Development Award.

THE POSITION:

To be responsible for preclinical efficacy and safety pharmacology programs and their scientific content and compliance with the international relevant guidelines; lead a team towards identification and preclinical development of novel therapeutic entities specifically in the areas of oncology, immuno-oncology, fibrosis.

CORE JOB RESPONSIBILITIES:

Design and manage non-clinical (preclinical) studies in all disciplines of in-vitro/in-vivo efficacy and safety pharmacology as well as in PK/PD and metabolism studies (ADME).
Provide the preclinical expertise in the area of novel drug target identification (proof of concept and mechanisms of action), establishment and validation of in vitro assays.
Represent Preclinical Function in project teams and work streams as needed.
Participate in due diligence activities, gap analysis and provide appropriate risk assessment.
Provide consultation to multiple program management teams and define strategies together with project team, in the design of experimental studies and protocols, interpretation of experimental results, review of study reports, and recommendations from the Contract Research Organization (CRO) or other performers in the area of responsibility.
Participate in the preparation and evaluation of the required preclinical (non-clinical) set of regulatory documents for the regulatory submission.
Participate in scientific peer review of Preclinical team output.

POSITION ACCOUNTABILITY / SCOPE:

Reports to Preclinical Development Director
Represents Preclinical Development Team in interactions with many functions in the Company
Ensures adequate and timely preclinical efficacy and safety pharmacology support for the Company

MINIMUM EXPERIENCE / REQUIREMENTS

Broad expertise and experience in preclinical R&D, experience in in-vitro/in-vivo preclinical efficacy and safety pharmacology, knowledgeable in general approaches in the preclinical development process, high level of ethical autonomy, proven ability to effectively work in complex, multifunctional regional and global teams. Aware of the International regulations (FDA, ICH, OECD, etc.). Fluency in the Russian & English languages is required.

EDUCATION:

Ph.D. (or equivalent) in a relevant area of Life Sciences and proven scientific expertise in all areas of preclinical efficacy and safety pharmacology.